This Week at FDA: Speedy Drug Review Bonuses, Makary Defends Prasad, and MoreFebruary 27, 2026February 28, 2026
This Week at FDA: Single Pivotal Trials, FDA Reverses Course to Review Moderna Flu Vaccine, and Makary’s OTC TurnFebruary 20, 2026February 28, 2026
This Week at FDA: QMSR and PreCheck Kickoff, Makary Tries to Ease CNPV Concerns, and MoreFebruary 6, 2026February 9, 2026
This Week at FDA: HHS Ends Aborted Fetal Tissue Research, PreCheck Pilot Update, and MoreJanuary 23, 2026February 5, 2026
This Week at FDA: Drug Voucher Program Hits a Snag, GOP Targets Abortion Drug, and MoreJanuary 16, 2026January 17, 2026
FDA and EMA Release Guiding Principles of Good AI Practice in Drug DevelopmentJanuary 14, 2026January 14, 2026
This Week at FDA: FDA Eases Digital Health Oversight, MDUFA Negotiation Update, and MoreJanuary 9, 2026January 14, 2026
This Week at FDA: FDA Staff Raise Alarm Over CNVP, No COVID-19 Vaccine Boxed Warning, and MoreDecember 19, 2025December 23, 2025
